Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting

[PR Newswire] – THOUSAND OAKS, Calif., Oct. 6, 2015 /PRNewswire/ — Amgen (AMGN) today announced that it will present data from multiple studies for Prolia® (denosumab) and investigational molecule romosozumab at the annual . . . → Read More: Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen To Give 23 Presentations On Osteoporosis Disease And Treatment At American Society For Bone And Mineral Research Annual Meeting Similar Articles: Company Update: Alexion Pharmaceuticals Inc (NASDAQ:ALXN) – Alexion Announces Presentations at 2015 American Society for Bone and Mineral Research Annual Meeting, Including New Data on Strensiq™ (asfotase alfa) in Children with Hypophosphatasia (HPP) Treated for Five Years Stock Update: Amgen Inc (NASDAQ:AMGN) – Amgen Receives Positive CHMP Opinion For Use Of Repatha™ (Evolocumab) For The Treatment Of High Cholesterol Market Update: Amgen Inc (NASDAQ:AMGN) – Amgen Announces Voting Results of Annual Meeting of Stockholders